Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...

Portland Treatment Center in Maine provides a wide range of services for those struggling with mental health and substance ...

Approximately 1 in 5 people develop cancer in their lifetime, and it continues to be one of the leading causes of mortality ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

People with acid reflux often rely on acid-reducing medications to ease symptoms. Depending on the severity of your symptoms, over-the-counter (OTC) and prescription options are available.

Celltrion, a major South Korean biopharmaceutical firm, on Friday said its new biosimilar for an autoimmune disease treatment has received approval from the US Food and Drug Administration (FDA). The ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...

Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.

Trump prioritizes criminalization over public health in fighting the overdose crisis. Experts say that doesn't work ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...